NAD+ is the best overall peptide for energy — it directly restores the mitochondrial cofactor responsible for ATP production, which declines with age. For physical stamina specifically, MOTS-C activates the AMPK pathway more acutely. For mental energy and focus, Semax is the strongest option. All three can be stacked.
| # | Compound | Best For | Availability | Speed of Effect | Details |
|---|---|---|---|---|---|
| 1 | NAD+Best Overall | Cellular energy, brain fog, general fatigue | TelehealthResearch | 1–3 days | Full guide → |
| 2 | MOTS-CBest Physical | Physical stamina, endurance, exercise capacity | TelehealthResearch | 2–4 weeks | Full guide → |
| 3 | SemaxBest Mental | Mental alertness, focus, cognitive energy | Research | Hours | Full guide → |
Why Energy Declines — and What Peptides Target
Chronic low energy is rarely caused by a single factor. The most common physiological drivers are mitochondrial dysfunction, declining NAD+ levels, reduced growth hormone output, and neurological fatigue. Peptides address these at the cellular level — which is fundamentally different from stimulants like caffeine, which only mask fatigue signals temporarily.
After age 30, NAD+ levels drop approximately 50% per decade. NAD+ is the primary electron carrier in the mitochondrial electron transport chain — the process that converts nutrients into ATP (the cell's energy currency). When NAD+ declines, mitochondria become less efficient, cells produce less ATP, and fatigue accumulates across muscle, brain, and organ tissue. This is why NAD+ is the starting point for most energy optimization protocols.
MOTS-C addresses a different mechanism: it activates AMP-activated protein kinase (AMPK), an enzyme that functions as the cell's energy sensor. When AMPK is activated, cells improve glucose uptake, enhance fat oxidation, and increase mitochondrial biogenesis — essentially getting better at producing energy, not just restoring a depleted input.
Semax works upstream in the nervous system. As an ACTH(4-7)PGP analogue, it increases brain-derived neurotrophic factor (BDNF) and modulates dopaminergic and serotonergic signaling — producing sharper cognitive function and mental stamina without the crash pattern of stimulants.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell of the body. It is the central electron carrier in cellular respiration — without adequate NAD+, mitochondria cannot efficiently convert food into ATP. Injectable NAD+ bypasses the conversion steps required by oral precursors (NR, NMN), delivering the active molecule directly into circulation for maximum bioavailability.
What it does for energy
NAD+ replenishment addresses fatigue at its root — not by stimulating the adrenal system, but by restoring the cell's capacity to produce energy. Clinical users consistently report improvements in three dimensions: physical endurance (less fatigue during exertion), cognitive clarity (reduced brain fog, sharper thinking), and sleep quality (deeper sleep, more restorative recovery). These effects compound over 4–8 weeks of consistent dosing.
Evidence
NAD+ has the most robust research base of any energy compound on this list. Multiple randomized controlled trials have demonstrated that NAD+ supplementation improves mitochondrial function in skeletal muscle, reduces inflammatory markers, and improves measures of physical performance in middle-aged and older adults. Intravenous NAD+ has been used clinically since the 1960s; subcutaneous injection is the current standard for outpatient telehealth protocols.
Who it's for
NAD+ is appropriate for anyone experiencing general fatigue, brain fog, poor sleep quality, or slow recovery from exercise — particularly adults over 35 where NAD+ decline becomes clinically significant. It is also commonly used as a foundational longevity compound and often stacked with MOTS-C or growth hormone peptides.
MOTS-C (mitochondrial open reading frame of the 12S rRNA-c) is a peptide encoded within mitochondrial DNA — not nuclear DNA — making it one of a newly recognized class of mitokines. It was first described by researchers at USC in 2015 and has attracted significant interest for its role in metabolic regulation and exercise-mimicking effects.
What it does for energy
MOTS-C activates AMPK and promotes insulin sensitivity in skeletal muscle, which increases glucose uptake and fat oxidation during activity. Crucially, it also upregulates mitochondrial biogenesis — triggering the production of new mitochondria within muscle cells. This is the same pathway activated by endurance exercise, which is why MOTS-C is often described as an "exercise mimetic." Users report notably improved physical stamina, faster recovery between training sessions, and reduced perceived exertion during intense effort.
Evidence
Animal studies show MOTS-C extends physical endurance, reduces adiposity, and improves metabolic markers comparably to aerobic exercise training. Human data is early-stage but consistent with the mechanism. Natural MOTS-C levels in the bloodstream increase with exercise — MOTS-C supplementation appears to replicate this signal pharmacologically.
Who it's for
MOTS-C is best suited for physically active individuals experiencing fatigue, reduced exercise capacity, or slower recovery — and for anyone looking to compound the effects of their training. It is a strong stack partner with NAD+ for a comprehensive cellular energy protocol.
Semax is a heptapeptide analogue of ACTH(4-10) developed in Russia, where it has been used clinically and studied for over three decades. It is structurally related to adrenocorticotropic hormone but stripped of the hormonal activity, retaining only the cognitive and neuroprotective effects. It is the most bioactive cognitive and mental energy compound available without a prescription.
What it does for energy
Semax's primary energy effect is neurological rather than mitochondrial. It increases BDNF (brain-derived neurotrophic factor) in the hippocampus and prefrontal cortex, modulates dopamine and serotonin systems, and improves blood flow to cerebral tissue. The practical result is acute mental alertness — sharper focus, faster processing, reduced mental fatigue — that users often notice within hours of the first dose. Unlike stimulants, it does not produce a rebound crash or tolerance escalation at standard doses.
Evidence
Russian clinical studies — the most extensive published data — show Semax improves cognitive performance in healthy adults and has demonstrated neuroprotective effects in stroke and cognitive decline research. BDNF upregulation is well-documented; this is the same pathway targeted by antidepressants and aerobic exercise. Semax's effect on BDNF is acute and consistent across studies.
Who it's for
Semax is best for professionals, students, or anyone whose primary energy concern is cognitive — mental fog, difficulty concentrating, low motivation, or demanding sustained focus. It stacks cleanly with NAD+ (which addresses the cellular energy substrate) and MOTS-C (physical stamina), providing a three-layer energy optimization protocol.
Side-by-Side Comparison
| Factor | NAD+ | MOTS-C | Semax |
|---|---|---|---|
| Primary mechanism | Mitochondrial cofactor replenishment | AMPK activation / mitochondrial biogenesis | BDNF upregulation / dopaminergic modulation |
| Energy type | Cellular + cognitive + physical | Physical stamina | Mental alertness / focus |
| Onset | 1–3 days | 2–4 weeks | Hours |
| Requires prescription | ✓ Telehealth | ✓ Telehealth / No (research) | No (research) |
| Research volume | Extensive (decades of data) | Emerging (2015–present) | Moderate (Russian clinical trials) |
| Stackable | Yes | Yes | Yes |
| Best entry point? | Yes — start here | Second add-on | Third (or alongside) |
How to Stack Energy Peptides
The three compounds above operate through complementary, non-overlapping pathways, which makes them unusually stack-friendly. A full energy optimization stack looks like this:
- Foundation (start here): NAD+ 50–100mg subcutaneous injection, 3–5×/week. Addresses the root cause — depleted cellular energy substrate.
- Add for physical stamina: MOTS-C 5–10mg, 2–3×/week. Activates the exercise-adaptive pathway and compounds with NAD+ at the mitochondrial level.
- Add for mental energy: Semax 300–600mcg intranasal or subcutaneous, daily or as needed. Targets the neurological dimension that NAD+ and MOTS-C don't directly address.
Most people notice the most dramatic improvement with NAD+ alone and add MOTS-C and Semax as refinements. Beginning with all three simultaneously makes it harder to attribute effects and adjust dosing. Start with NAD+ for 4–6 weeks, then layer.
Where to Get Energy Peptides
NAD+ is available through telehealth clinics as a physician-prescribed compound — this is the recommended route for most people, as it includes lab work, dosing guidance, and medical oversight. Research vendors carry NAD+, MOTS-C, and Semax without a prescription for research use only.
- Telehealth (supervised): Defy Medical, Marek Health, and PeterMD all prescribe NAD+ and MOTS-C as part of comprehensive protocols (~$150–$200/month).
- Research vendors: NextGenPeps carries all three compounds. Use code 3LUIZH10 for a discount.
For detailed pricing and provider tables for each compound, see the individual guides: NAD+ guide, MOTS-C guide, Semax guide.
Frequently Asked Questions
Not sure where to start?
Use our goal picker to see the best compounds and exact pricing for your specific situation.
Find My Peptide →